William C. Koller
#110,730
Most Influential Person Now
William C. Koller's AcademicInfluence.com Rankings
William C. Kollerphilosophy Degrees
Philosophy
#4644
World Rank
#7239
Historical Rank
Logic
#2060
World Rank
#2959
Historical Rank
William C. Kollerbiology Degrees
Biology
#6101
World Rank
#8744
Historical Rank
Neuroscience
#722
World Rank
#754
Historical Rank
Download Badge
Philosophy Biology
William C. Koller's Degrees
- Doctorate Medicine Stanford University
Why Is William C. Koller Influential?
(Suggest an Edit or Addition)William C. Koller's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. (1993) (1186)
- Variable expression of Parkinson's disease (1990) (1167)
- International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study (2006) (912)
- Effect of deprenyl on the progression of disability in early Parkinson's disease. (1989) (886)
- Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy (1996) (814)
- Essential tremor. (1989) (642)
- An algorithm (decision tree) for the management of Parkinson’s disease (2001): (1998) (591)
- Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. (2003) (538)
- High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor (1997) (493)
- Factors impacting on quality of life in Parkinson's disease: Results from an international survey (2002) (467)
- Falls and Parkinson's disease. (1989) (362)
- The effect of deprenyl and levodopa on the progression of Parkinson's disease (1995) (341)
- An algorithm (decision tree) for the management of Parkinson's disease (1998) (336)
- Age at onset in two common neurodegenerative diseases is genetically controlled. (2002) (332)
- Complete genomic screen in Parkinson disease: evidence for multiple genes. (2001) (302)
- Long‐term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor (2001) (288)
- Treatment interventions for Parkinson's disease: an evidence based assessment (2002) (280)
- The relationship of essential tremor to other movement disorders: Report on 678 patients (1994) (280)
- Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. (1989) (274)
- High-frequency stimulation of the globus pallidus for the treatment of Parkinson's disease (1997) (245)
- Movement disorders : neurologic principles and practice (1997) (232)
- Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. (2003) (224)
- The diagnosis of manganese-induced parkinsonism. (2006) (215)
- Sensory symptoms in Parkinson's disease (1984) (213)
- Parkin mutations and susceptibility alleles in late‐onset Parkinson's disease (2003) (212)
- When does Parkinson's disease begin? (1992) (210)
- A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor (2001) (205)
- An R5L τ mutation in a subject with a progressive supranuclear palsy phenotype (2002) (202)
- PAINFUL PARKINSON'S DISEASE (1986) (201)
- Criteria for the diagnosis of essential tremor. (2000) (196)
- Bilateral subthalamotomy in Parkinson's disease: initial and long-term response. (2005) (195)
- Lexical, semantic, and action verbal fluency in Parkinson's disease with and without dementia. (1999) (195)
- Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. (2001) (190)
- Blood flow responses to deep brain stimulation of thalamus (2002) (180)
- Subthalamic deep brain stimulation and impulse control in Parkinson’s disease (2009) (179)
- Weight change and body composition in patients with Parkinson's disease. (1995) (172)
- United Parkinson Foundation Neurotransplantation Registry on adrenal medullary transplants (1991) (171)
- Neuropsychological deficits in essential tremor: an expression of cerebello‐thalamo‐cortical pathophysiology? (2002) (167)
- Handbook of tremor disorders (1995) (165)
- Comparison of thalamotomy to deep brain stimulation of the thalamus in essential tremor (2001) (164)
- Unilateral pallidal stimulation for Parkinson's disease: Neurobehavioral functioning before and 3 months after electrode implantation (1997) (164)
- Acute and chronic effects of propranolol and primidone in essential tremor (1989) (162)
- Neuropsychological impairment in Parkinson's disease with and without depression. (1995) (159)
- The gait abnormality of Huntington's disease (1985) (158)
- Tremors in early Parkinson's disease. (1989) (154)
- Oxidation reactions in Parkinson's disease. Discussion (1990) (150)
- MECHANISM OF ACTION (2019) (147)
- Chorea induced by oral contraceptives (1979) (147)
- Clinical expression of essential tremor: Effects of gender and age (1997) (146)
- Sexual dysfunction in Parkinson's disease. (1990) (145)
- Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism. (2001) (144)
- Pramipexole in patients with early Parkinson's disease. (1995) (144)
- Environmental risk factors in Parkinson's disease (1990) (143)
- Immediate-release and controlled-release carbidopa/levodopa in PD (1999) (141)
- Apolipoprotein E controls the risk and age at onset of Parkinson disease (2004) (140)
- Is essential tremor benign? (1991) (139)
- Risk factors for dementia in Parkinson's disease: effect of education. (1996) (139)
- Bilateral thalamic stimulation for the treatment of essential tremor. (1999) (136)
- Interactive video conferencing: A means of providing interim care to parkinson's disease patients (1993) (134)
- Neuropsychological and quality of life outcome after thalamic stimulation for essential tremor (1999) (130)
- Topiramate in essential tremor (2006) (129)
- How accurately can Parkinson's disease be diagnosed? (1992) (127)
- Efficacy of unilateral deep brain stimulation of the vim nucleus of the thalamus for essential head tremor (1999) (124)
- Double‐blind controlled trial of gabapentin in essential tremor (1998) (121)
- Functional correlates of pallidal stimulation for Parkinson's disease (2001) (120)
- Muscle strength testing in Parkinson's disease. (1986) (118)
- Efficacy of primidone in essential tremor (1986) (118)
- Immediate-release and controlled-release carbidopa/levodopa in PD A 5-year randomized multicenter study (1999) (113)
- Calcification of the basal ganglia (1979) (110)
- Pharmacologic treatment of parkinsonian tremor. (1986) (102)
- Movement disorders and AIDS: a review. (2004) (102)
- Botulinum toxin treatment of essential head tremor (1995) (102)
- Modification of postsynaptic dopaminergic sensitivity by female sex hormones. (1979) (102)
- Posttraumatic movement disorders: A review (1989) (101)
- Tremor disorders. Diagnosis and management. (1995) (101)
- Apolipoprotein E genotypes in Parkinson's disease with and without dementia (1995) (101)
- Neuropsychological and quality of life outcomes 12 months after unilateral thalamic stimulation for essential tremor (2003) (101)
- Clozapine use in Parkinson's disease: A retrospective analysis of a large multicentered clinical experience (1998) (100)
- Therapy of Parkinson's disease (1990) (100)
- Benefits and Risks of Pharmacological Treatments for Essential Tremor (2003) (99)
- Estrogen treatment of dyskinetic disorders (1982) (99)
- The Behavioral Complications of Pallidal Stimulation: A Case Report (2000) (99)
- Drug holiday and management of Parkinson disease (1980) (96)
- Unilateral stimulation of the subthalamic nucleus in Parkinson disease: a double-blind 12-month evaluation study. (2004) (96)
- Essential tremor in twins (2001) (95)
- Abnormal performance on the PD test battery by asymptomatic first-degree relatives (1999) (94)
- Deep brain stimulation for essential tremor (1996) (94)
- Gender differences in Parkinson's disease. (1998) (93)
- The influence of depression on cognition in Parkinson's disease (1995) (92)
- Long term safety and efficacy of unilateral deep brain stimulation of the thalamus for parkinsonian tremor (2001) (91)
- Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpoint (1999) (90)
- Olfactory function in essential tremor (1992) (90)
- Lack of association between essential tremor and Parkinson's disease (1988) (90)
- Benztropine versus clozapine for the treatment of tremor in Parkinson's disease (1997) (88)
- Sydenham chorea (1980) (88)
- Mechanism of action of dopaminergic agents in Parkinson's disease (1998) (87)
- Reduction in voice tremor under thalamic stimulation (1998) (87)
- Motor Complications of Chronic Levodopa Therapy in Parkinson's Disease (1997) (85)
- Disability in essential tremor (1986) (83)
- An algorithm for the management of Parkinson's disease. (1994) (83)
- Dysfluency (stuttering) in extrapyramidal disease. (1983) (82)
- Effect of alcohol on tremors (1984) (82)
- Deep brain stimulation of the Vim nucleus of the thalamus for the treatment of tremor. (2000) (81)
- Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease (1996) (81)
- Levodopa therapy in Parkinson's disease (1990) (79)
- Post‐traumatic midbrain tremors (1990) (78)
- Environmental risk factors in siblings with Parkinson's disease. (1991) (78)
- Randomized trial of tolcapone versus pergolide as add‐on to levodopa therapy in Parkinson's disease patients with motor fluctuations (2001) (77)
- Effects of thalamic deep brain stimulation based on tremor type and diagnosis (1997) (77)
- Does a long preclinical period occur in Parkinson's disease? (1991) (76)
- Pharmacologic treatment of essential tremor. (2000) (75)
- Construct validity of the WCST in normal elderly and persons with Parkinson's disease. (1995) (74)
- Utility of a Wisconsin Card Sorting Test short form in persons with Alzheimer's and Parkinson's disease. (1996) (73)
- Early detection of probable idiopathic Parkinson's disease: II. A prospective application of a diagnostic test battery (2000) (71)
- Health-Related Quality of Life in Parkinson's Disease after Pallidotomy and Deep Brain Stimulation (2000) (70)
- Autologous transplantation of adrenal medulla in Parkinson's disease. 18-month results. (1990) (70)
- Essential tremor in twins: An assessment of genetic vs environmental determinants of etiology (2001) (68)
- Subcutaneous apomorphine in patients with advanced Parkinson's disease: A dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose (2007) (67)
- Cerebellar atrophy demonstrated by computed tomography (1981) (67)
- Essential tremor (1987) (66)
- Cognitive outcome following staged bilateral pallidal stimulation for the treatment of Parkinson’s disease (1999) (65)
- Issues in the early diagnosis of Parkinson's disease (1997) (64)
- Differentiation of the Dementias of Alzheimer's and Parkinson's Disease with the Dementia Rating Scale (1995) (64)
- Disturbance of Recent Memory Function in Parkinsonian Patients on Anticholinergic Therapy (1984) (63)
- Pharmacologic trials in the treatment of cerebellar tremor. (1984) (63)
- Motor initiation and execution in essential tremor and Parkinson's disease (2000) (62)
- The next frontier in Parkinson's disease (1991) (62)
- Association study of Parkin gene polymorphisms with idiopathic Parkinson disease. (2003) (62)
- Accuracy of reported family histories of essential tremor (1996) (61)
- Diagnostic validity of the dementia questionnaire for Alzheimer disease. (1998) (61)
- Effect of Motor Improvement on Quality of Life following Subthalamic Stimulation Is Mediated by Changes in Depressive Symptomatology (2004) (60)
- Neuropsychological and Quality of Life Changes Following Unilateral Thalamic Deep Brain Stimulation in Parkinson's Disease: A One-Year Follow-up (2001) (60)
- Clinical experience with controlled‐release carbidopa/levodopa in Parkinson's disease (1993) (60)
- Pharmacologic Treatment of Tremor (2008) (59)
- Is there a relationship between Parkinson's disease and essential tremor? (1993) (59)
- Transdermal dopaminergic D2 receptor agonist therapy in Parkinson's disease with N‐0923 TDS: A double‐blind, placebo‐controlled study (2001) (59)
- Psychogenic tremors (1989) (58)
- Tremor-Predominant Parkinson’s Disease (2000) (58)
- Volitional control of involuntary movements (1989) (57)
- Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group. (1995) (57)
- The core assessment program for intracerebral transplantation. (1995) (56)
- Dapsone-induced peripheral neuropathy. (1977) (56)
- Improvements in daily functioning after deep brain stimulation of the thalamus for intractable tremor (1998) (55)
- A comparison of Parkinson's disease symptoms and self-reported functioning and well being. (1997) (54)
- The Effects of Different Repeated Doses of Entacapone on the Pharmacokinetics of L-Dopa and on the Clinical Response to L-Dopa in Parkinson's Disease (2001) (53)
- Effect of levodopa treatment for parkinsonism in welders (2004) (52)
- Relationship of aging to Parkinson's disease. (1987) (52)
- Combined resting-postural tremors. (1985) (52)
- Epidemiology and Genetics of Essential Tremor (2008) (52)
- Early detection of probable idiopathic Parkinson's disease: I. development of a diagnostic test battery (2000) (52)
- Surgical treatment of Parkinson’s disease (1999) (52)
- Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's disease (2000) (51)
- Clinical usefulness of the Parkinson's disease sleep scale. (2005) (50)
- Chronic Electrical Stimulation of the Left Ventrointermediate (Vim) Thalamic Nucleus for the Treatment of Pharmacotherapy-Resistant Parkinson's Disease: A Differential Impact on Access to Semantic and Episodic Memory? (1998) (49)
- Essential tremor and dystonia (1993) (49)
- Nutritional aspects and swallowing function of patients with Parkinson's disease. (1990) (49)
- Long‐acting propranolol in essential tremor (1985) (49)
- Effect and Time Course of Deep Brain Stimulation of the Globus Pallidus and Subthalamus on Motor Features of Parkinson's Disease (2000) (48)
- An open-label evaluation of the tolerability and safety of Stalevo® (carbidopa, levodopa and entacapone) in Parkinson’s disease patients experiencing wearing-off (2005) (47)
- Cerebellar atrophy demonstrated by computed tomography (1981) (47)
- Paraquat and Parkinson's disease (1986) (46)
- Adjuvant therapy of parkinsonian tremor. (1987) (46)
- Chronic dopaminergic sensitivity after Sydenham's chorea (1983) (46)
- Tremor in chronic alcoholism (1985) (46)
- Diagnosis and treatment of tremors. (1984) (46)
- Surgical treatment of essential tremor. (2000) (45)
- Analysis of pallidotomy lesion positions using three-dimensional reconstruction of pallidal lesions, the basal ganglia, and the optic tract. (1997) (45)
- Influence of female sex hormones on neuroleptic-induced behavioral supersensitivity (1980) (45)
- Senile gait: Correlation with computed tomographic scans (1983) (44)
- Gene-Toxin Interaction as a Putative Risk Factor for Parkinson’s Disease with Dementia (1998) (44)
- Unmet medical needs in Parkinson’s disease (2004) (44)
- Quinpirole hydrochloride, a potential anti-parkinsonism drug (1987) (43)
- Alcoholism in essential tremor (1983) (43)
- Dose-response relationship of propranolol in the treatment of essential tremor. (1986) (43)
- Early detection of probable idiopathic Parkinson's disease: I. Development of a diagnostic test battery. (2000) (42)
- Essential Tremor Variants: Effect of Treatment (1987) (41)
- Electromyographic guidance of botulinum toxin treatment in cervical dystonia. (1991) (40)
- Nocardia species as an etiologic agent in Parkinson's disease: serological testing in a case-control study (1995) (40)
- Controlled-release carbidopa-levodopa: old drug--new drug. Introduction. (1992) (39)
- Treating motor fluctuations with controlled-release levodopa preparations. (1994) (38)
- Nadolol in essential tremor (1983) (38)
- Failure of fixed-dose, fixed muscle injection of botulinum toxin in torticollis. (1990) (37)
- Propranolol therapy for essential tremor of the head (1984) (37)
- The pharmacological evaluation of pergolide mesylate as a potential anti-Parkinson agent (1980) (37)
- Serotonin, dopamine, and motor effects in Parkinson's disease. (1997) (37)
- Correlation between essential tremor and migraine headache. (1990) (37)
- Primitive reflexes and cognitive function in the elderly (1982) (36)
- Historical review: Abnormal movements associated with epidemic encephalitis lethargica (1987) (35)
- A controlled trial of lazabemide (Ro 19-6327) in levodopa-treated Parkinson's disease. Parkinson Study Group. (1994) (35)
- Methazolamide for essential voice tremor (1996) (35)
- Thalamic stimulation for midbrain tremor after partial hemangioma resection (2002) (34)
- Handedness and essential tremor. (1985) (34)
- Classification of essential tremor. (1992) (33)
- Parkinson's disease. Update in diagnosis and symptom management. (2001) (33)
- Senile gait. A distinct neurologic entity. (1985) (33)
- Motor signs are infrequent in dementia of the Alzheimer type (1984) (32)
- Thalamic Deep Brain Stimulation for Tremor (2000) (31)
- Pallidotomy microelectrode targeting: neurophysiology-based target refinement. (2000) (31)
- Diabetes mellitus presenting as paroxysmal kinesigenic dystonic choreoathetosis (1995) (31)
- Early Parkinson’s Disease (2000) (31)
- “Interactive video conferencing” in the provision of neuropsychological services to rural areas (1995) (30)
- Metoprolol compared with propranolol in the treatment of essential tremor. (1984) (30)
- Pramipexole in Levodopa-treated Parkinson Disease Patients of African, Asian, and Hispanic Heritage (2007) (29)
- Tradozone in essential tremor. Probe of serotoninergic mechanisms. (1989) (29)
- Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled study. (2001) (29)
- The α-synuclein gene is not a major risk factor in familial Parkinson disease (1999) (29)
- Anticholinergic therapies in the treatment of Parkinson's disease (2002) (28)
- Speech therapy in Parkinson's disease (2002) (28)
- Prevalence of movement disorders in an elderly nursing home population. (2008) (28)
- Adrenal medullary autografts in patients with Parkinson's disease. (1989) (28)
- Comparison of standard carbidopa–levodopa and sustained‐release carbidopa–levodopa in parkinson's disease: Pharmacokinetic and quality‐of‐life measures (1997) (27)
- Time course of a single oral dose of propranolol in essential tremor (1985) (27)
- Cerebellar atrophy (1981) (27)
- Essential tongue tremor (1987) (26)
- Normal distribution of apolipoprotein E alleles in progressive supranuclear palsy (1996) (26)
- Psychogenic movement disorders. (1995) (26)
- Neuroprotective Therapy for Parkinson's Disease (1997) (26)
- Pharmacologic probe with progabide of GABA mechanisms in essential tremor. (1987) (26)
- Complications of chronic levodopa therapy (1981) (26)
- Writing tremor: its relationship to essential tremor. (1986) (25)
- Initiating treatment of Parkinson's disease (1992) (24)
- Neuropsychological functioning before and after unilateral thalamic stimulating electrode implantation in Parkinson's disease (1997) (24)
- Efficacy and safety of stereotaxic surgical treatment of tremor disorders (1996) (24)
- D1 and D2 dopamine receptor mechanisms in dopaminergic behaviors. (1988) (24)
- Linear Pharmacokinetic Behavior of Ropinirole during Multiple Dosing in Patients with Parkinson's Disease (2000) (23)
- The effect of acetazolamide on essential tremor (1992) (23)
- Other formulations and future considerations for apomorphine for subcutaneous injection therapy (2004) (23)
- Usefulness of a writing aid in writer's cramp (1989) (22)
- Terguride, a mixed dopamine agonist‐antagonist, in animal models of Parkinson's disease (1987) (22)
- United Parkinson Foundation Neurotransplantation Registry: multicenter US and Canadian data base, presurgical and 12 month follow-up. (1990) (22)
- Hemiballism and tremor due to ependymal cyst (1992) (21)
- Pallidotomy lesion locations: significance of microelectrode refinement. (1998) (21)
- A novel formulation of selegiline for the treatment of Parkinson’s disease (2004) (21)
- Chorea and contraceptives: Case report with pet study and review of the literature (2004) (21)
- Clonidine in the treatment of essential tremor (1986) (20)
- Absence of the apolipoprotein E ε4 allele is associated with working memory impairment in Parkinson's disease (2006) (20)
- Early morning akinesia in Parkinson's disease (1996) (20)
- Effects of selegiline dosing on motor fluctuations in Parkinson's disease. (1993) (20)
- Questionnaire Assessment Potentially Overestimates Anxiety in Parkinson's Disease (2001) (20)
- Amantadine and other antiglutamate agents (2002) (19)
- Autologous adrenal medullary transplant in progressive supranuclear palsy (1989) (19)
- Cognitive impairment in Parkinson's disease (1998) (19)
- Genetic testing in Huntington's disease (1984) (19)
- The diagnosis of Parkinson's disease. (1984) (19)
- Neuroprotection for parkinson's disease (1998) (19)
- Pemoline‐induced chorea (1981) (19)
- Surgical treatment options in Parkinson's disease. (1998) (19)
- Psychogenic parkinsonism. (1995) (18)
- Cerebellar calcification on computerized tomography (1980) (18)
- Comparison of NART and Barona demographic equation premorbid IQ estimates in Alzheimer's disease. (1997) (18)
- Alcohol and Parkinson disease (1983) (18)
- Phenytoin and choreic movements. (1978) (18)
- Neuroprotection in parkinson’s disease: An elusive goal (2004) (18)
- The effects of withdrawal of dopaminergic medication in nursing home patients with advanced parkinsonism. (2008) (17)
- Alternate day levodopa therapy in parkinsonism (1982) (17)
- Treatment of depression in idiopathic Parkinson's disease (2002) (17)
- Comparison of Actual Pallidotomy Lesion Location with Expected Stereotactic Location (1999) (17)
- Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson’s disease (2003) (17)
- Nicotine and tremor. (1988) (17)
- The alpha-synuclein gene is not a major risk factor in familial Parkinson disease. (1999) (17)
- Phenytoin‐induced cerebellar degeneration (1980) (16)
- Predicting Parkinson's disease. Discussion (1990) (16)
- Pharmacokinetic comparison of sinemet and atamet (Generic carbidopa/levodopa): A single‐dose study (1996) (16)
- INH in multiple sclerosis (1984) (16)
- Thalamic stimulation reduces essential tremor but not the delayed antagonist muscle timing (2002) (15)
- Adult‐onset foot dystonia (1984) (15)
- Prevalence of Parkinson’s Disease in Bulgarian Gypsies (2000) (15)
- Chronic autoreceptor blockade and neuroleptic-induced dopamine receptor hypersensitivity (1987) (14)
- Drugs to treat dementia and psychosis (2002) (14)
- Tardive dystonia: treatment with trihexyphenidyl. (1985) (14)
- The parkinsonian personality. (1995) (14)
- Influence of demographic variables on the Dementia Rating Scale. (1995) (14)
- Absence of the apolipoprotein E epsilon4 allele is associated with working memory impairment in Parkinson's disease. (2006) (13)
- The Parkinson's disease symptom inventory (PDSI): a comprehensive and sensitive instrument to measure disease symptoms and treatment side-effects. (1999) (13)
- Levodopa in the treatment of Parkinson's disease. (2000) (13)
- Management of motor fluctuations in Parkinson's disease. (1996) (13)
- Lesion Volume and Clinical Outcome in Stereotactic Pallidotomy and Thalamotomy (1999) (13)
- Methods of Managing Levodopa-Induced Dyskinesias (1996) (13)
- MAO‐B inhibitors for the treatment of Parkinson's disease (2002) (13)
- A new drug for treatment of essential tremor? Time will tell. (1991) (12)
- Does a long preclinical period occur in Parkinson's disease? (1991) (12)
- Complete genomic screen in Parkinson Disease (2001) (12)
- Chapter 8: Pharmacology of Ballismus (1979) (11)
- Selegiline monotherapy in the treatment of Parkinson's disease (1996) (11)
- Advances in the treatment of Parkinson's disease. (1998) (11)
- Diagnostic testing in movement disorders. (1996) (11)
- Selegiline HCl : selective MAO-type B inhibitor. Discussion (1990) (11)
- Tremor disorders of aging: diagnosis and management. (1989) (11)
- Introduction. Essential tremor. (2000) (11)
- Dapsone-lnduced Neuropathy (1977) (11)
- Amitriptyline‐induced abnormal movements (1985) (11)
- Quality of life and Parkinson’s disease: The CR FIRST Study (1998) (10)
- Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Patients taking selegeline may have received more levodopa than necessary. (1996) (10)
- Clinical and experimental studies of phenytoin-induced hyperkinesias (2005) (10)
- Hereditary Paroxysmal Cerebellopathy: Responsiveness to Acetazolamide (1987) (10)
- Patients taking selegiline may have received more levodopa than necessary (1996) (10)
- Drugs to treat autonomic dysfunction in Parkinson's disease (2002) (9)
- Evaluation of ciladopa hydrochloride as a potential anti-parkinson drug (1986) (9)
- Dopamine agonists in the treatment of Parkinson's disease. (1995) (9)
- Modification of evoked responses in the caudate nucleus by cholinergic agents (1976) (9)
- PHNO, a novel dopamine agonist, in animal models of parkinsonism (1987) (9)
- Pindolol-induced tremor. (1987) (8)
- Surgical treatment for Parkinson's disease: Deep brain surgery (2002) (8)
- Erratum: Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease (Human Molecular Genetics (2003) vol. 12 (3259-3267)) (2004) (8)
- Movement Disorders in Neurology and Neuropsychiatry, 2nd ed (2000) (8)
- Can we improve the holistic assessment of Parkinson's disease? The development of a non-motor symptom questionnaire and scale for Parkinson's disease. (2004) (7)
- Magnetic resonance image evaluation of pallidotomy lesions: a volumetric and shape analysis. (1997) (7)
- Sensory symptoms (1985) (7)
- Controlled‐release levodopa (1993) (7)
- Essential tremor: The beginning of a new era (1997) (7)
- Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease. (2000) (7)
- Selegiline HCl: Selective MAO‐type B inhibitor (1990) (6)
- DA agonists ‐ Ergot derivaties: Cabergoline (2002) (6)
- Lithium ineffective in dystonia (1983) (6)
- Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA. (1996) (6)
- DA agonists ‐ Non‐Ergot derivaties: Ropinirole (2002) (6)
- ESSENTIAL TREMOR. AUTHOR'S REPLY (1992) (6)
- Task‐specific dystonias (1989) (6)
- Individualizing therapy in patients with disabling Parkinson's disease symptoms (1994) (6)
- Effects of intermittent haloperidol treatment on dopamine receptor sensitivity in guinea pigs (2004) (6)
- Psychosocial counseling in Parkinson's disease (2002) (6)
- High incidence of cardiopulmonary complications associated with implantation of adrenal medullary tissue into the caudate nucleus in patients with advanced neurologic disease (1991) (6)
- Primitive Reflexes in the Evaluation of the Aging Patient (1984) (6)
- Treatment of early Parkinson’s disease (2002) (6)
- Deep brain stimulation for parkinson's disease and tremor (2000) (6)
- Surgical treatment for Parkinson's disease: Neural transplantation (2002) (6)
- Bromocriptine: decreased clinical effects at higher dosages. (1979) (6)
- Reply from the Supplement Editors (1995) (6)
- Age of onset of Parkinson's disease. (1987) (5)
- Preclinical detection of Parkinson's disease. The next frontier: presymptomatic detection. Introduction. (1991) (5)
- Amantadine in essential tremor (1984) (5)
- Physical and occupational therapy in Parkinson's disease (2002) (5)
- Current and emerging drug therapies in the management of Parkinson's disease (1998) (5)
- DA agonists ‐ Non‐Ergot derivaties: Apomorphine (2002) (4)
- Comparative Magnetic Resonance Image-Based Evaluation of Thalamotomy and Pallidotomy Lesion Volumes (1999) (4)
- Movement disorders, A comprehensive survey by William J. Weiner and Anthony E. Lang Mit Kisco, NY, Futura Publishing Co 735 pp, illustraed, $125 (1990) (4)
- Disseminated Histoplasmosis in the Acquired Immune Deficiency Syndrome (2016) (4)
- Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia (1984) (4)
- What is it? Case 1, 1987: Unusual tremors, bradykinesia, and cerebral lucencies (1987) (4)
- Psychogenic tremors. (1989) (3)
- Effect of levodopa treatment for parkinsonism in welders: A double-blind study. (2004) (3)
- Dopa-Responsive Parkinsonism Secondary to Right Temporal Lobe Haemorrhage (2002) (3)
- Ineffectiveness of phenoxybenzamine in essential tremor. (1986) (3)
- Surgical Treatment of Parkinson's Disease: Past, Present, and Future (2002) (3)
- Evidence for Multiple Genes (2001) (3)
- Erythrocyte thiolmethyltransferase (1995) (3)
- Idiopathic oral-facial dyskinesia. (1988) (3)
- Effect of MK-458 (HPMC) in Parkinson's disease previously untreated with dopaminergic drugs. A double-blind, placebo-controlled multicenter study. (1991) (3)
- DA agonists ‐ Ergot derivaties: Lisuride (2002) (3)
- Electroencephalogram in Tardive Dyskinesia (1984) (3)
- THE NEXT FRONTIER : PRESYMPTOMATIC DETECTION (1991) (3)
- Dapsone-induced neuropathy. (1977) (2)
- Cortical disinhibitory signs (1983) (2)
- Evaluation of tremor disorders. (1990) (2)
- Differential diagnosis of parkinsonism. (2003) (2)
- Effect of pergolide mesylate, an ergoline, in animal models of Parkinson's disease: implications for therapy. (1979) (2)
- Essential tremor (1992) (2)
- Estrogen in experimental tardive dyskinesia (1981) (2)
- Tremor-Predominant Parkinson's DiseaseTo Treatment (2000) (2)
- Recognizing early Parkinson's disease. (1991) (2)
- What is it? Case 2, 1994: Parkinsonism and cognitive impairment (1994) (2)
- Duration of effectiveness of primidone in essential tremor (1986) (1)
- Memory in Neurodegenerative Disease: Drug treatment of cognitive impairment in neurodegenerative disease: rationale, current experience and expectations for the future (1998) (1)
- Chapter 3 – Other Drug Therapies for Parkinson's Disease (2005) (1)
- Intermittent levodopa therapy in parkinsonism. (1983) (1)
- Verbal memory in Parkinson's disease with and without depression: Comparisons and contrasts with Alzheimer's disease (1996) (1)
- DA agonists ‐ Non‐Ergot derivaties: Pramipexole (2002) (1)
- Reply to "declining medication requirement in some patients with advanced Parkinson disease and dementia". (2004) (1)
- Movement disorders. (2003) (1)
- Is There a Relationship Between Essential Tremor and Parkinson's Disease? (1987) (1)
- Transient foot dystonia in an adult woman (1985) (1)
- Neuroepidemiology of Parkinson’s Disease: Environmental Influences (1994) (1)
- Parkinsonism: is your treatment appropriate? (1980) (1)
- Diagnosis of parkinsonism in the elderly (2000) (1)
- The History of Essential Tremor (2005) (1)
- DA agonists ‐ Ergot derivaties: Dihydroergocryptine (DHEC) (2002) (1)
- Complications of chronic levodopa therapy (1981) (1)
- Parkinson's disease and parkinsonism in the elderly: Essential tremor in the elderly (2000) (1)
- Maintenance of Tremor Control Over Time in Patients with Essential Tremor Using Chronic Thalamic Stimulation: 780 (1997) (1)
- Edentulousness and oral dyskinesia. (1983) (1)
- DA agonists ‐ Non‐Ergot derivaties: Piribedil (2002) (1)
- Verbal learning and memory in neuropsychologically defined subgroups of Parkinson's disease patients (1996) (0)
- Strategies for treating complications of levodopa therapy (1994) (0)
- Parkinson's disease slide library (1996) (0)
- Propranolol in essential tremor (1985) (0)
- Dopaminergic agonists in Parkinson's disease (1992) (0)
- Prevalence of spontaneous lingual‐facial‐buccal dyskinesias (1983) (0)
- Chapter 10 Hyperkinetic Movement Disorders (2001) (0)
- American Society for Stereotactic and Functional Neurosurgery Bestows Distinguished Service Award on Dr. med. h.c. mult. Thomas Karger and Prof. Dr. Phil Gildenberg (2004) (0)
- Subject Index Vol. 80, 2003 (2004) (0)
- Letters to the editor (1995) (0)
- Visual Cues in Essential Tremor (2000) (0)
- Health and social needs of people with Parkinson ’ s disease and the worldwide organization of their care (2000) (0)
- 3.226 The frequency and magnitude of impulse control deficits in Parkinson's disease patients with deep brain stimulation of the subthalamic nucleus (2007) (0)
- Acoustic analysis of essential voice tremor (1991) (0)
- DA agonists ‐ Ergot derivaties: Bromocriptine (2002) (0)
- Alteration of basal ganglia evoked responses by reserpine and L-Dopa (1976) (0)
- Reply (1996) (0)
- Long-Term Benefits Shown for Thalamic Stimulation in Essential Tremor (2004) (0)
- Paraquat and Parkinson's disease (1987) (0)
- Attenuation by pergolide of haloperidol-induced striatal dopamine receptor density. (1984) (0)
- Drug-Induced Movement Disorders (1993) (0)
- Reply (1989) (0)
- Rare and unusual parkinsonian syndromes. (1999) (0)
- The comprehensive mangement of parkinson's disease Edited by Matthew Stern and Howard Hurtig New York, PMA Publishing Corp, 1988 191 pp (1989) (0)
- Cerebellar atrophy and schizophrenia. (1982) (0)
- Weekly drug holiday in PD (1982) (0)
- Subject Index Vol. 71, 1998 (1999) (0)
- PAST 3 Surgical Treatment of Parkinson ' s Disease Past , Present , and Future (0)
- Development and pilot study of the first nonmotor symptom screening questionnaire and scale for Parkinson's disease using an international multidisciplinary approach. (2004) (0)
- Parkinson's disease and movement disorders, Edited by J. Jankwic and E. Tolosa Baltimore, Urban and Schwarzenberg, 1988 499 pp, illustrated (1990) (0)
- Comprar Parkinsons Disease and Related Disorders Part I | William C. Koller | | Elsevier (2007) (0)
- Estrogens and dyskinesia (1984) (0)
- Adrenal neural transplants in Parkinson's disease. (1990) (0)
- Time course of a single oral dose of propranolol in essential tremor (1986) (0)
- The IDPN model of hyperkinesias (1984) (0)
- Non-parkinsonian tremor. (1992) (0)
- Chorea induced by oral contraceptives (1980) (0)
- Magnitude of Microelectrode Refinement in Pallidotomy and Thalamotomy1 (2002) (0)
- Thalamotomy vs. DBS of the Thalamus (2002) (0)
- The evolving role of monoamine oxidase inhibitors in the treatment of Parkinson’s disease (2004) (0)
- Twelfth annual symposia on etiology, pathogenesis, and treatment of parkinson's disease and etiology, pathogenesis, and treatment of Huntington's disease (1998) (0)
- Drugs to treat urinary frequency, urgency, and/or urge incontinence (2002) (0)
- Differential diagnosis of Parkinson's disease (1992) (0)
- WAIS-R NI information and vocabulary subtest performance in Parkinson's disease (1996) (0)
- DA agonists ‐ Overview (2002) (0)
- Aid in writer's cramp (1989) (0)
- Reply to Chu (2018) (0)
- Reply (1985) (0)
- Characterization of Tau Association with Parkinson's Disease (2003) (0)
- Drugs to treat gastrointestinal motility problems (2002) (0)
- To the Editor (1991) (0)
- Alcohol improves dystonia (1986) (0)
- Pallidal Stimulation for Advanced Parkinson's Disease: 775 (1997) (0)
- Contents Vol. 71, 1998 (1999) (0)
- PARKINSON'S DISEASE RISK FACTORS. AUTHORS' REPLY (1994) (0)
- Reply (1996) (0)
- Comprar Parkinson's Disease and Related Disorders Part II | William C. Koller | 9780444528933 | Elsevier (2007) (0)
- Parkinson's disease and parkinsonism in the elderly: Index (2000) (0)
- National Academy of Neuropscyhology: Abstract from the 15th annual meeting San Francisco, CA, November 1, 2, 3, & 4, 1995WAIS-R NI information and vocabulary subtest performance in Parkinson's disease (1996) (0)
- Parkinson's disease and related disorders (2007) (0)
- Bromocriptine (1979) (0)
- Memory in Neurodegenerative Disease: Neurochemical aspects of memory dysfunction in neurodegenerative disease (1998) (0)
- Reply from the Authors (1996) (0)
- Essential tremor. (1992) (0)
- Patients taking selegiline may have received more levodopa than necessary (1996) (0)
This paper list is powered by the following services:
